174 results
Search Results
2. The Great Mimicker: Metastatic Breast Carcinoma to the Head and Neck with Emphasis on Unusual Clinical and Pathologic Features
3. LINC01806 Promotes Breast Cancer Growth and Metastasis via Sponging miR-1286 to Disinhibit ZEB1 Expression
4. The emerging role of breast cancer derived extracellular vesicles-mediated intercellular communication in ovarian cancer progression and metastasis
5. Apelin receptor antagonist boosts dendritic cell vaccine efficacy in controlling angiogenic, metastatic and apoptotic-related factors in 4T1 breast tumor-bearing mice
6. Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation
7. Identifying breast cancer recurrence histories via patient-reported outcomes
8. Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer
9. Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases
10. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer
11. Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
12. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function
13. A systems biology approach to discovering pathway signaling dysregulation in metastasis
14. Epigenetic regulation of breast cancer metastasis
15. Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
16. Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer
17. TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties
18. The effect of ELOVL6 fatty acid elongase inhibition on the expression of genes associated with the metastasis of breast cancer
19. Estimating the incidence of breast cancer recurrence using administrative data
20. Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype
21. Is invasion a necessary step for metastases in breast cancer?
22. Hallmarks of Bone Metastasis
23. Long Non-Coding RNA LINC00052 Targets miR-548p/Notch2/Pyk2 to Modulate Tumor Budding and Metastasis of Human Breast Cancer
24. Patterns of breast cancer second recurrences in patients after mastectomy
25. A Molecular View of Pathological Microcalcification in Breast Cancer
26. MicroRNAs as therapeutic targets in breast cancer metastasis
27. Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression
28. Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression
29. Cancer Stem Cells Under Hypoxia as a Chemoresistance Factor in the Breast and Brain
30. Long non-coding RNA ARHGAP5-AS1 inhibits migration of breast cancer cell via stabilizing SMAD7 protein
31. Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies
32. RETRACTED ARTICLE: Roles of MicroRNAs and Other Non-coding RNAs in Breast Cancer Metastasis
33. ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism
34. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis
35. Informing the new developments and future of cancer immunotherapy: Future of cancer immunotherapy
36. NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis
37. Distant metastases do not metastasize
38. Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
39. BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer
40. Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors
41. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment
42. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
43. The Impact of Anti-tumor Agents on ER-Positive MCF-7 and HER2-Positive SKBR-3 Breast Cancer Cells Biomechanics
44. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer
45. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis
46. Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?
47. The next generation personalized models to screen hidden layers of breast cancer tumorigenicity
48. Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
49. Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations
50. Mucin 2 (MUC2) modulates the aggressiveness of breast cancer
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.